MAINZ BIOMED NV (MYNZ) Forecast, Price Target & Analyst Ratings

NASDAQ:MYNZ • NL0015000LC2

Current stock price

0.8441 USD
+0.02 (+2.07%)
At close:
0.7672 USD
-0.08 (-9.11%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MAINZ BIOMED NV (MYNZ).

Forecast Snapshot

Consensus Price Target

Price Target
$14.28
+ 1,591.74% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 30, 2026
Period
Q3 / 2025
EPS Estimate
-$2.04
Revenue Estimate
408K
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$14.28
Upside
+ 1,591.74%
From current price of $0.84 to mean target of $14.28, Based on 7 analyst forecasts
Low
$14.14
Median
$14.28
High
$14.70

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for MYNZ. The average price target is 14.28 USD. This implies a price increase of 1591.74% is expected in the next year compared to the current price of 0.8441.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

MYNZ Current Analyst RatingMYNZ Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

MYNZ Historical Analyst RatingsMYNZ Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
MYNZ was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about MYNZ.
In the previous month the buy percentage consensus was at a similar level.
MYNZ was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-02-14Maxim GroupInitiate Buy
2024-11-25HC Wainwright & Co.Downgrade Buy -> Neutral
2024-04-12Cantor FitzgeraldReiterate Neutral
2024-03-06HC Wainwright & Co.Maintains Buy -> Buy
2023-11-21Cantor FitzgeraldDowngrade Overweight -> Neutral
2023-11-20HC Wainwright & Co.Maintains Buy -> Buy
2023-09-26Cantor FitzgeraldReiterate Overweight -> Overweight
2023-09-22HC Wainwright & Co.Maintains Buy -> Buy
2023-09-14Cantor FitzgeraldReiterate Overweight -> Overweight
2023-08-22Cantor FitzgeraldReiterate Overweight -> Overweight
2023-08-18HC Wainwright & Co.Reiterate Buy -> Buy
2023-06-01HC Wainwright & Co.Reiterate Buy
2023-05-18Cantor FitzgeraldMaintains Overweight -> Overweight
2023-04-27HC Wainwright & Co.Maintains Buy
2023-03-30HC Wainwright & Co.Reiterate Buy
2023-02-16HC Wainwright & Co.Reiterate Buy
2023-02-10JonesTradingInitiate Buy
2022-10-25Cantor FitzgeraldInitiate Overweight
2022-06-21HC Wainwright & Co.Initiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 30, 2026
Period
Q3 / 2025
EPS Estimate
-$2.04
Revenue Estimate
408K
Revenue Q2Q
33.33%
EPS Q2Q
54.55%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

MYNZ is expected to report earnings on 3/30/2026. The consensus EPS estimate for the next earnings is -2.04 USD and the consensus revenue estimate is 408.00K USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
MYNZ revenue by date.MYNZ revenue by date.
530K
-8.62%		895.5K
68.96%		894K
-0.17%		891.48K
-0.28%		936.36K
5.03%		2.542M
171.48%		30.765M
1,110.27%		75.503M
145.42%		153.18M
102.88%		222.78M
45.44%		268.5M
20.52%		318.62M
18.67%
EBITDA
YoY % growth
MYNZ ebitda by date.MYNZ ebitda by date.
-26.13M
-170.78%		-25.778M
1.35%		-17.401M
32.50%		N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
MYNZ ebit by date.MYNZ ebit by date.
-26.51M
-172.74%		-26.645M
-0.51%		-18.418M
30.87%		-17.583M
4.54%		-19.441M
-10.57%		-23.365M
-20.18%		-9.783M
58.13%		18.594M
290.07%		69.761M
275.18%		129.61M
85.79%		162.39M
25.29%		262.09M
61.40%
Operating Margin
MYNZ operating margin by date.MYNZ operating margin by date.
-5,001.89%-2,975.40%-2,060.20%-1,972.31%-2,076.25%-919.16%-31.80%24.63%45.54%58.18%60.48%82.26%
EPS
YoY % growth
MYNZ eps by date.MYNZ eps by date.
N/A-48.05
31.13%		N/A
63.45%		-2.92
83.39%		-1.38
52.80%		-1.50
-8.89%		-0.04
97.28%		0.27
750.00%		0.66
150.00%		0.92
38.46%		N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-2.04
54.55%		-2.04
44.44%
Revenue
Q2Q % growth		408K
33.33%		408K
9.32%
EBITDA
Q2Q % growth		N/AN/A
EBIT
Q2Q % growth		N/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

MYNZ Yearly Revenue VS EstimatesMYNZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
MYNZ Yearly EPS VS EstimatesMYNZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -20 -40 -60

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
24.17%
EPS Next 5 Year
15.04%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
32.90%
Revenue Next 5 Year
133.71%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

MAINZ BIOMED NV / MYNZ Forecast FAQ

Can you provide the average price target for MAINZ BIOMED NV stock?

7 analysts have analysed MYNZ and the average price target is 14.28 USD. This implies a price increase of 1591.74% is expected in the next year compared to the current price of 0.8441.

When does MAINZ BIOMED NV (MYNZ) report earnings?

MAINZ BIOMED NV (MYNZ) will report earnings on 2026-03-30, after the market close.

Can you provide the consensus estimates for MAINZ BIOMED NV next earnings?

The consensus EPS estimate for the next earnings of MAINZ BIOMED NV (MYNZ) is -2.04 USD and the consensus revenue estimate is 408.00K USD.

How do analysts rate MAINZ BIOMED NV (MYNZ)?

The consensus rating for MAINZ BIOMED NV (MYNZ) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.